Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects

OBJECTIVE: DA-8031 is a selective serotonin reuptake inhibitor under development for the treatment of premature ejaculation. This is the first-in-human study aimed at evaluating the pharmacokinetics and tolerability of DA-8031 and its metabolites (M1, M2, M4, and M5) in the plasma and urine after ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Dongseong, Lee, SeungHwan, Yi, Sojeong, Yoon, Seo Hyun, Cho, Joo-Youn, Bahng, Mi Young, Jang, In-Jin, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354528/
https://www.ncbi.nlm.nih.gov/pubmed/28331291
http://dx.doi.org/10.2147/DDDT.S126861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354528/
https://www.ncbi.nlm.nih.gov/pubmed/28331291
http://dx.doi.org/10.2147/DDDT.S126861

Ejemplares similares